MX2017006748A - Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades. - Google Patents

Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.

Info

Publication number
MX2017006748A
MX2017006748A MX2017006748A MX2017006748A MX2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A MX 2017006748 A MX2017006748 A MX 2017006748A
Authority
MX
Mexico
Prior art keywords
disease
symptoms
treatment
amino acid
acid compositions
Prior art date
Application number
MX2017006748A
Other languages
English (en)
Inventor
B Dennison Daniel
Vidyasagar Sadasivan
J Gatto Stephen
Original Assignee
Entrinsic Health Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entrinsic Health Solutions Inc filed Critical Entrinsic Health Solutions Inc
Publication of MX2017006748A publication Critical patent/MX2017006748A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención objeto proporciona composiciones terapéuticas, y sus usos para el tratamiento o mejora de síntomas de una enfermedad seleccionada del grupo que consiste de: infección por virus de ébola, infección por HIV, ataxia, enteropatía ambiental, cáncer, resaca, enfermedad inflamatoria y diarrea epidémica porcina. En modalidades preferidas, la composición incluye una combinación de uno o más aminoácidos seleccionados del grupo que comprende de lisina, acido aspártico, glicina, isoleucina, treonina, tirosina, valina, triptófano, asparagina y/o serina.
MX2017006748A 2014-11-24 2015-11-19 Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades. MX2017006748A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462083698P 2014-11-24 2014-11-24
US201562138051P 2015-03-25 2015-03-25
PCT/US2015/061462 WO2016085735A1 (en) 2014-11-24 2015-11-19 Amino acid compositions for the treatment of symptoms of disease

Publications (1)

Publication Number Publication Date
MX2017006748A true MX2017006748A (es) 2017-08-28

Family

ID=56074902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006748A MX2017006748A (es) 2014-11-24 2015-11-19 Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.

Country Status (8)

Country Link
US (5) US20170326088A1 (es)
EP (3) EP3616689A1 (es)
JP (1) JP2017535591A (es)
CN (1) CN107106527B (es)
BR (1) BR112017010832A2 (es)
CA (1) CA2968831A1 (es)
MX (1) MX2017006748A (es)
WO (1) WO2016085735A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115645388B (zh) * 2016-10-04 2024-12-10 佛罗里达大学研究基金会公司 氨基酸组合物及其用途
JP2019043861A (ja) * 2017-08-30 2019-03-22 アサヒグループホールディングス株式会社 乳酸／ピルビン酸比の改善用組成物
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
JP2021520351A (ja) * 2018-04-04 2021-08-19 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 皮膚を治療するための組成物
IT201800005599A1 (it) * 2018-05-22 2019-11-22 Lente a contatto morbida
CN108434304A (zh) * 2018-05-23 2018-08-24 北京雄九医学研究院 防癌抗癌中药的制备方法
EP4084784A4 (en) * 2020-01-13 2024-01-17 Monash University Compositions and methods
IL299488A (en) * 2020-07-02 2023-02-01 Univ Florida Preparations for promoting hydration and methods of using them
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6130394A (en) 1991-03-05 1994-08-15 Miris Medical Corporation Apparatus for providing a timed release of an amount of aerosol medication
DE69230613T2 (de) 1991-07-02 2000-12-28 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
HUP9800049A3 (en) 1995-02-23 1999-01-28 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
MXPA01002875A (es) 1998-11-13 2002-04-08 Los Angeles Childrens Hospital Metodos para facilitar el crecimiento vascular.
CN100379357C (zh) 2000-01-14 2008-04-09 博德·哈塔森 用于喂养水生生物的海洋类脂组合物
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US7063865B2 (en) * 2002-05-10 2006-06-20 Jeremy Park Jones Composition and method for substantially reducing the deleterious effects of alcohol on the body
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20070010459A1 (en) 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
CN101815441A (zh) * 2007-08-03 2010-08-25 安敏诺技术公司 氨基酸和肽产品
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397861B1 (it) * 2010-01-27 2013-02-04 Ambrosialab Srl Metodo e composizioni per l'applicazione di aminoacidi sulla pelle mediante un mezzo anidro
GB201012539D0 (en) 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
MX350541B (es) 2010-09-24 2017-09-08 Univ Florida Materiales y metodos para mejorar la funcion gastrointestinal.
CN103458890A (zh) * 2011-04-12 2013-12-18 雀巢产品技术援助有限公司 包括支链脂肪酸的营养组合物及其使用方法
EP2782566B1 (en) * 2011-11-21 2021-01-06 The Institute for Ethnomedicine L-serine as for use in treating neurodegenerative disorders
HK1204290A1 (en) * 2012-02-08 2015-11-13 University Of Florida Research Foundation, Inc. Materials and methods for treating diarrhea
US9987306B2 (en) * 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract

Also Published As

Publication number Publication date
CN107106527A (zh) 2017-08-29
US20250049744A1 (en) 2025-02-13
CN107106527B (zh) 2020-11-24
US20200368194A1 (en) 2020-11-26
EP3616689A1 (en) 2020-03-04
EP3223809A1 (en) 2017-10-04
EP3223809A4 (en) 2018-08-15
US11357747B2 (en) 2022-06-14
US10758506B2 (en) 2020-09-01
US20170326088A1 (en) 2017-11-16
CA2968831A1 (en) 2016-06-02
US20220347143A1 (en) 2022-11-03
EP3459540A1 (en) 2019-03-27
BR112017010832A2 (pt) 2017-12-26
US12161614B2 (en) 2024-12-10
US20180289648A1 (en) 2018-10-11
JP2017535591A (ja) 2017-11-30
WO2016085735A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
CL2016001405A1 (es) A peptide mixture
EP4417256A3 (en) Materials and methods for improving lung function
EA201790465A1 (ru) Антитела, композиции и применение
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX359201B (es) Polipeptidos que se unen al complemento humano 5 (c5).
UA118167C2 (uk) Пептид та його застосування
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
MX2016003942A (es) Proteinas de union a desmogelina 2 (dsg2) y usos de los mismos.
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
CL2017002729A1 (es) Proteína de unión a rgma y su uso
EA201990298A1 (ru) Способы и композиции для лечения рака
EA201692552A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
MX378754B (es) Métodos y reactivos para la prevención y/o el tratamiento de infecciones.
MX2022011972A (es) Composiciones que comprenden anticuerpos contra il6r para el tratamiento de la uveitis y el edema macular, y metodos de uso de las mismas.
MX2010010457A (es) Vectores recombinantes de rinovirus.
EA201791937A1 (ru) Противовоспалительные полипептиды
EA201891527A1 (ru) Композиции и способы обнаружения и лечения рака пищевода
CU20210061A7 (es) Composición vacunal que comprende el dominio alfa 3 de mica/b para el tratamiento del cáncer
MX373409B (es) Composiciones para fibras de queratina.
DK3658133T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme
MX362058B (es) Péptido pntx(19) sintético, composición farmacéutica y uso.